{"name":"4th Annual Genome Editing USA Congress","series":"","short":"","website":"http://bit.ly/2KyWvP8","content":"350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing. 80+ case studies, solution & technology presentations & 2 interactive workshops over the 2 days. 07 April 2019 – Day One • Genome Editing Technologies & Techniques • Drug Discovery & Development Applications in In Vivo Therapeutics 08 April 2019 – Day Two • Drug Discovery & Development – Target Identification and Validation • Non-Human Models in Diagnostics & Therapeutics View Agenda: http://bit.ly/2rLMzeL 2020 Live Webinar Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc. Tuesday, 10 March 2020 | 03:30 PM GMT Register: https://bit.ly/2QvO7Us","date_start":"2020-03-16","date_end":"","important_dates":{"abstract":"","full":"2020-03-16","notification":"","final":""},"topics":["Medicine & Health","Pharmaceutical / Medicinal"],"location":{"virtual":"","full":["Boston","United States"],"name":"","street":"","city":"Boston","state":"","ZIP":"","country":"United States"},"organizers":[""],"societies":[],"indexes":[],"emails":[]}